1. CRRT:  Early or Late? Ashita Tolwani, MD, MS – University of Alabama at Birmingham

 

 

 

 

2. Antibiotic Dosing in CRRT – Nithin Karakala, MD – University of Arkansas for Medical Sciences

 

 

 

 

3. Recreational Drugs in AKI Luis Juncos, MD – University  of Mississippi

 

 

 

 

4. The Role of Klotho in the Transition from Acute to Chronic Kidney Disease – Javier Neyra, MD – University of Kentucky

 

 

 

5. Post AKI Care and Risk Prediction After AKI – Edward Siew, MD – Vanderbilt University

 

 

6. Treatment of Hepatorenal Syndrome Juan Carlos Velez, MD – Ochsner Clinic Foundation

 

 

 

 

7. AKI Pathology and Cases with Audience Response – Shree Sharma, MD, FASN – Arkana Laboratories

 

 

 

 

 

8. Morning Discussion

 

 

9. The Central Role of the Podocyte in Glomerular Diseases – Stuart Shankland, MD, ChB, MBA, FRCP – University of Washington

 

 

 

10. The Glomcon Initiative – Ali Poyan Mehr, MD – Beth Israel Deaconess Medical Center

 

 

 

 

 

11. Precision Medicine in Lupus Nephritis:  Is it in Our Future? – Dawn Caster, MD, FASN – University of Louisville

 

 

12. Glomerular Pathology and Cases with Audience Response – Nicholas Cossey, MD – Arkana Laboratories

 

 

 

 

 

13. Drug Induced Glomerular Disease: Mechanisms and Pathology – Jonathan Hogan, MD – University of Pennsylvania

 

 

 

 

 

14. Kidney Disease in the African American Patient.  The Clinico-Pathologic Spectrum of APOL1-Associated Nephropathy. – Christopher Larsen, MD – Arkana Laboratories

 

 

 

 

 

  15. Afternoon Discussion